Eicosanoid aspects of atherosclerosis.
Willis
A L
AL
Institute of Biological Sciences, Syntex Research, Palo Alto, CA 94304.
Smith
D L
DL
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology*; D004041:Dietary Fats / Q000009:adverse effects; D015118:Eicosapentaenoic Acid / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D006801:Humans; D009569:Nitric Oxide / Q000494:pharmacology; D011465:Prostaglandins, Synthetic / Q000494:pharmacology
D004041:Dietary Fats; D005231:Fatty Acids, Unsaturated; D011465:Prostaglandins, Synthetic; D009569:Nitric Oxide; D015118:Eicosapentaenoic Acid